|
|
|
|
| LEADER |
03112nam a22003255i 4500 |
| 001 |
978-0-387-30172-3 |
| 005 |
20190619192834.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2006 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780387301723
|
| 024 |
7 |
|
|a 10.1007/0-387-30172-0
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a N-Acetylaspartate
|b A Unique Neuronal Molecule in the Central Nervous System /
|c edited by John Moffett, Suzannah B. Tieman, Daniel R. Weinberger, Joseph T. Coyle, Aryan M. A. Namboodiri.
|
| 250 |
|
|
|a 1st ed. 2006.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2006.
|
| 300 |
|
|
|a XVII, 375 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a A Brief Overview of N-Acetylaspartate and N-Acetylaspartylglutamate -- Expression of N-Acetylaspartate and N-Acetylaspartylglutamate in the Nervous System -- N-Acetylaspartate Metabolism in Neural Cells -- Naa Synthesis and Functional Roles -- Identity of the High-Affinity Sodium/Carboxylate Cotransporter NaC3 as the N-Acetyl-L-Aspartate Transporter -- Canavan Disease: Studies on the Knockout Mouse -- Functions Of N-Acetylaspartate and N-Acetylaspartylglutamate in Brain -- Control of Brain Volume during Hypoosmolality and Hyperosmolality -- Physiological Role of N-Acetylaspartate -- Defective Myelin Lipid Synthesis as a Pathogenic Mechanism of Canavan Disease -- Mutation Analysis of the Aspartoacylase Gene in Non-Jewish Patients with Canavan Disease -- Does ASPA Gene Mutation in Canavan Disease Alter Oligodendrocyte Development? -- Quantitation of NAA in the Brain by Magnetic Resonance Spectroscopy -- N-Acetyl-L-Aspartate in Multiple Sclerosis -- NAA and Higher Cognitive Function in Humans -- In Vivo NMR Measures of NAA and the Neurobiology of Schizophrenia -- N-Acetylaspartate as a Marker of Neuronal Injury in Neurodegenerative Disease -- Regulation of NAA-Synthesis in the Human Brain in Vivo: Canavan’s Disease, Alzheimer’s Disease and Schizophrenia -- Magnetic Resonance Spectroscopy for Monitoring Neuronal Integrity in Amyotrophic Lateral Sclerosis -- Hypoacetylaspartia: Clinical and Biochemical Follow-Up of a Patient -- Cellular Localization of NAAG -- Synthesis of N-Acetylaspartylglutamate (NAAG) and N-Acetylaspartate (NAA) in Axons and Glia of the Crayfish Medial Giant Nerve Fiber -- NAAG as a Neurotransmitter -- Glutamate Carboxypeptidase II (NAALADase) Inhibition as a Novel Therapeutic Strategy -- N-Acetylaspartylglutamate (NAAG) in Spinal Cord Injury and Disease -- N-Acetylaspartylglutamate (NAAG) in Pelizaeusmerzbacher Disease -- Concluding Remarks.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
1 |
4 |
|a Neurosciences.
|
| 700 |
1 |
|
|a Moffett, John.
|e editor.
|
| 700 |
1 |
|
|a Tieman, Suzannah B.
|e editor.
|
| 700 |
1 |
|
|a Weinberger, Daniel R.
|e editor.
|
| 700 |
1 |
|
|a Coyle, Joseph T.
|e editor.
|
| 700 |
1 |
|
|a Namboodiri, Aryan M. A.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/0-387-30172-0
|